Chinook Therapeutics Inc (KDNY) · page 8 of 36
The slide argues that the drug Atrasentan acts as a 'band-aid' by masking symptoms via surrogate endpoints without providing long-term structural benefit.
Research note · appendix_data · analyze_data · dense density
Slide locked Sign in to view
Slide schematic 6/6
chart 1/1 paragraph 2/2 source-note 1/1 table 1/1 title 1/1
Components 6
line paragraph paragraph source-note data action-title
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.